BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6602652)

  • 21. The in vitro response of turkey lymphocytes to steroid hormones.
    Redig PT; Dunnette JL; Mauro L; Sivanandan V; Markham F
    Avian Dis; 1985; 29(2):373-83. PubMed ID: 4026731
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation of steroid hormone sensitivity of human breast cancer cells in culture (MCF-7) by a colony formation method].
    Nomura Y; Matsui K; Tashiro H; Hamada Y; Saeki K
    Gan To Kagaku Ryoho; 1983 May; 10(5):1335-41. PubMed ID: 6870300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic and ultrastructural aspects of the in vitro lysis of chronic lymphocytic leukemia cells by glucocorticoids.
    Galili U; Leizerowitz R; Moreb J; Gamliel H; Gurfel D; Polliack A
    Cancer Res; 1982 Apr; 42(4):1433-40. PubMed ID: 7060016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of leukaemia blast colony growth by steroid hormones.
    Taetle R; Guittard JP
    Br J Haematol; 1982 Feb; 50(2):247-55. PubMed ID: 6949611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activated autologous T cells exert an anti-B-cell chronic lymphatic leukemia effect in vitro and in vivo.
    Di Ianni M; Moretti L; Terenzi A; Bazzucchi F; Del Papa B; Bazzucchi M; Ciurnelli R; Lucchesi A; Sportoletti P; Rosati E; Marconi PF; Falzetti F; Tabilio A
    Cytotherapy; 2009; 11(1):86-96. PubMed ID: 19153855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucosylceramide synthase inhibitors sensitise CLL cells to cytotoxic agents without reversing P-gp functional activity.
    Gerrard G; Butters TD; Ganeshaguru K; Mehta AB
    Eur J Pharmacol; 2009 May; 609(1-3):34-9. PubMed ID: 19285492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diminished DNA synthesis in T cells from B chronic lymphocytic leukemia after phytohemagglutinin, anti-CD3, and phorbol myristate acetate mitogenic signals.
    Prieto A; Garcia-Suarez J; Reyes E; Lapeña P; Hernandez M; Alvarez-Mon M
    Exp Hematol; 1993 Nov; 21(12):1563-9. PubMed ID: 8405237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribonucleotide content of mononuclear cells from normal subjects and patients with chronic lymphocytic leukemia: increased nicotinamide adenine dinucleotide concentration in chronic lymphocytic leukemia lymphocytes.
    Liebes LF; Krigel RL; Conklyn M; Nevrla DR; Silber R
    Cancer Res; 1983 Nov; 43(11):5608-17. PubMed ID: 6604577
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of some steroid hormones on the growth of Trichomonas vaginalis].
    Martinotti MG; Savoia D
    G Batteriol Virol Immunol; 1985; 78(1-6):52-9. PubMed ID: 3879810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in constitutive and activation-induced expression of CD69 and CD95 between normal and chronic lymphocytic leukemia B cells.
    De Fanis U; Romano C; Dalla Mora L; Sellitto A; Guastafierro S; Tirelli A; Bresciano E; Giunta R; Lucivero G
    Oncol Rep; 2003; 10(3):653-8. PubMed ID: 12684639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticancer drugs: effect on the cloning of Raji lymphoma cells in soft agar.
    Wu PC; Ozols RF; Hatanaka M; Boone CW
    J Natl Cancer Inst; 1982 Jan; 68(1):115-21. PubMed ID: 6948121
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytotoxicity of adriamycin and daunorubicin for normal and leukemia progenitor cells of man.
    Buick RN; Messner HA; Till JE; McCulloch EA
    J Natl Cancer Inst; 1979 Feb; 62(2):249-55. PubMed ID: 310906
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
    Pu Q; Bianchi P; Bezwoda WR
    Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel cell surface antigen (T305) found in increased frequency on acute leukemia cells and in autoimmune disease states.
    Fox RI; Hueniken M; Fong S; Behar S; Royston I; Singhal SK; Thompson L
    J Immunol; 1983 Aug; 131(2):762-7. PubMed ID: 6602845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selenite is a potent cytotoxic agent for human primary AML cells.
    Olm E; Jönsson-Videsäter K; Ribera-Cortada I; Fernandes AP; Eriksson LC; Lehmann S; Rundlöf AK; Paul C; Björnstedt M
    Cancer Lett; 2009 Sep; 282(1):116-23. PubMed ID: 19345479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of selective killing by steroids in normal and malignant cells.
    Weichselbaum RR; Little JB; Nove J; Hellman S; Piro AJ
    J Cell Physiol; 1980 Jun; 103(3):429-33. PubMed ID: 7400225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colony-forming assay for circulating chronic lymphocytic leukemia cells.
    Taetle R; Richardson D; To D; Royston I; Mendelsohn J
    Leuk Res; 1982; 6(3):335-44. PubMed ID: 7121052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic lymphocytic leukemia lymphocytes: membrane anomalies and H2O2 vulnerability.
    Silber R; Stahl RL; Farber CM; Kanganis D; Astrow A; Liebes LF
    Blood Cells; 1984; 10(2-3):233-9. PubMed ID: 6336165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.